CDH1 and gastric cancer: Although the gene mutations of CDH1 and RHOA distinguished GC from colorectal and esophageal tumors, and these mutations were specific to diffuse-type GC, it is still challenging to discriminate the intestinal-type and diffuse-type GC in molecular gene expression networks [4].